This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RABBIT ANTI MAPK8 / JNK1
catalog :
AHP2322
quantity :
50 µg
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
product information
Entity Category :
Antibodies
Product Code :
AHP2322
Description :
RABBIT ANTI MAPK8 / JNK1
Specificity :
MAPK8 / JNK1
Target Species :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
IP, P, WB
Application Types :
Western Blotting, Immunohistology - Paraffin, Immunoprecipitation
Cross Reactivities :
Mouse, Rat
Quantity :
50 µg
Quantity Value :
50 µg
Quantity Type :
µg
GO Accessions :
GO:0005515, GO:0002755, GO:0002756, GO:0005829, GO:0004705, GO:0005524, GO:0005654, GO:0008063, GO:0008629, GO:0008633, GO:0009411, GO:0034130, GO:0034134, GO:0034138, GO:0034142, GO:0043066, GO:0045087, GO:0048011, GO:0051090, GO:0051403
GO Terms :
alpha-2 macroglobulin receptor-associated protein activity, c-Jun N-terminal kinase activity, down regulation of apoptosis, downregulation of apoptosis, down-regulation of apoptosis, GO:0002226, GO:0045308, induction of pro-apoptotic gene products, inhibition of apoptosis, JNK, JNK3alpha1, MAPK11 cascade, MAPK12 cascade, MAPK13 cascade, MAPK14 cascade, MyD88-dependent TLR signaling pathway, MyD88-dependent toll-like receptor signalling pathway, MyD88-independent TLR signaling pathway, MyD88-independent toll-like receptor signalling pathway, nerve growth factor receptor signalling pathway, NGF receptor signaling pathway, NGF receptor signalling pathway, nonspecific immune response, p38 cascade, p38 MAPK signaling, p38 MAPK signalling, protein amino acid binding, protein degradation tagging activity, protein folding chaperone, protein tagging activity, response to ultraviolet light stimulus, response to ultraviolet radiation stimulus, response to UV light stimulus, response to UV radiation stimulus, SAPK cascade, SAPK1, stress-activated MAPK signaling pathway, stress-activated MAPK signalling pathway, stress-activated MAPKKK cascade, stress-activated MAPKKK signaling pathway, stress-activated MAPKKK signalling pathway, Tl signaling pathway, Tl signalling pathway, TLR1 signaling pathway, TLR2 signaling pathway, TLR3 signaling pathway, TLR4 signaling pathway, Toll signalling pathway, toll-like receptor 1 signalling pathway, toll-like receptor 2 signalling pathway, toll-like receptor 3 signalling pathway, toll-like receptor 4 signalling pathway
Uniprot Accessions :
P45983
Gene :
MAPK8
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5599
Published Synonyms :
JNK1
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.